Insmed (INSM) Reports Q2 Loss of $0.72/Share
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $120.82 --0%
EPS Growth %: +77.7%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +77.7%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.72), versus ($0.59) reported last year.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- General Mills posts lower Q1 sales, reaffirms fiscal 2027 targets
- Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
